#USA #Princeton #Regulatory Writing #ZYLiQ #clinical reports

ZYLiQ's Version 4.0: A Leap in Regulatory Writing Automation

On October 22, 2025, ZYLiQ, an industry leader in AI-driven regulatory medical writing solutions, announced the launch of its latest version, 4.0. This new version is set to transform the landscape of regulatory documentation by significantly enhancing automation and efficiency in clinical reporting processes.

Recognized for its groundbreaking application of generative AI, ZYLiQ has managed to reduce the time taken to generate clinical study reports by an impressive 75%. The company's commitment to innovation is underscored by a high customer renewal rate, reflecting the positive impact of its technology in overcoming regulatory writing challenges.

Key Features of ZYLiQ Version 4.0

The newly introduced version includes several enhancements aimed at increasing the automation of clinical study reports:

• - Automatic Source Type Prediction: ZYLiQ now informs users about the source type for user-added content, ensuring accuracy and relevancy in reporting.
• - Optimized Synthesis Content Creation: The platform aids in generating succinct and coherent synthesis content.
• - AI-Driven Time Conversion and Summarization: Automated transformations of verb tenses, concise writing, and in-text summarizations are powered by generative AI.
• - AI-Assisted Conclusions Writing: The new version facilitates the drafting of concluding sections concerning safety and efficacy, promoting clarity and precision.

In addition, ZYLiQ 4.0 introduces new modules tailored for various types of regulatory documents. These enhancements include:

• - Safety Data Presentation: This feature automates the data extraction process from lists, SDTM/ADaM datasets, and patient profiles. Clients report an impressive 90% reduction in execution time.
• - Informed Consent Form Generation: By integrating protocol content and investigator brochures, ZYLiQ aids in the creation of automated informed consent forms, providing sponsor-specific templates.
• - Clear Language Summary: This module automatically generates a layperson's summary derived from the clinical study report, enhancing transparency.
• - Protocol Summary in Simple Language: Similar to the previous feature, this tool creates an accessible protocol summary.
• - Document Redaction and Anonymization: Ensuring confidentiality, this feature allows for the masking or anonymization of sensitive information in all types of documents.

Free Pilot Trial Offer

To validate its claims of efficiency and innovation, ZYLiQ is offering potential clients a two-week free pilot trial. This opportunity allows them to compare existing regulatory writing processes with the accelerated automation capabilities marketed by ZYLiQ.

According to Farha Feroze, the creator of ZYLiQ and Product Management Director, “By focusing specifically on regulatory document automation instead of scattering our efforts across multiple document types, we have managed to develop an exceptionally effective solution. With Version 4.0, we are excited to extend the same level of innovation beyond clinical study reports to other regulatory documents. I take pride in what my team has accomplished, advancing the application of cutting-edge technologies.”

About ZYLiQ

With three decades of experience as part of the contract research organization Symbiance, ZYLiQ combines deep knowledge in the life sciences with proven innovation capabilities in AI and machine learning. Their comprehensive understanding of clients’ challenges ensures tailored solutions that meet regulatory writing needs.

For more information or to request a demonstration, visit ZYLiQ’s website or contact via phone at +1 949-878-2121.